Aarey Drugs Financials

NSE: AAREYDRUGS | BSE: 524412

₹98.89

₹3.18 (3.32%)

As on 11-Sep-2026IST

Market cap

₹306 Cr

Revenue (TTM)

₹415 Cr

P/E Ratio

73.4

P/B Ratio

1.9

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Operating Revenue	414.69	473.94	397.65	418.96	492.76	348.42
Total Income	420.95	483.76	402.58	421.69	495.43	355.43
Total Expenditure	407.89	471.05	391.17	411.23	481.37	343.77
EBITDA	6.80	2.90	6.48	7.72	11.40	4.65
Depreciation	3.22	1.94	1.70	1.57	1.99	0.92
EBIT	3.58	0.95	4.78	6.15	9.41	3.73
Interest	5.64	4.66	4.38	2.87	2.04	2.44
Other Income	6.26	9.81	4.94	2.73	2.67	7.01
Exceptional Items	--	--	--	--	--	--
Profit before Tax	4.20	6.10	5.34	6.01	10.04	8.30
Provision for Tax	0.03	2.08	0.66	2.24	3.48	1.79
Profit after Tax	4.18	4.02	4.68	3.77	6.55	6.51

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Shareholder's Funds	150.42	138.48	132.77	117.41	113.64	98.86
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.75	2.91	3.97	5.78	4.80	3.37
Current Liabilities	145.08	149.21	166.55	168.14	126.74	130.80
Total Liabilities	297.25	290.59	303.29	291.32	245.17	233.04

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Non-Current Assets	27.89	24.98	20.71	20.72	26.35	14.66
Current Assets	262.94	265.61	282.59	270.61	218.82	218.38
Total Assets	297.25	290.59	303.29	291.32	245.17	233.04
Total Debt*	--	34.86	31.35	37.72	14.16	18.02
Net Current Assets	117.87	116.40	116.04	102.47	92.08	87.57
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Cash From Operating Activities	--	10.30	-2.99	-1.28	0.50	5.48
Cash Flow from Investing Activities	--	-5.94	-1.70	0.44	-3.21	-2.88
Cash from Financing Activities	--	-4.48	5.58	1.35	2.25	-2.45
Net Cash Inflow / Outflow	--	-0.12	0.89	0.51	-0.46	0.15

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Adjusted EPS (₹)	1.47	1.41	1.67	1.49	2.58	2.79
Cash EPS (₹)	1.35	2.10	2.27	2.11	3.37	3.18
Adjusted Book Value (₹)	53.01	47.78	46.45	45.34	43.85	41.29
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	3.62	-1.07	-0.50	0.20	2.34
Free Cash Flow per Share (₹)	--	0.09	-2.41	-2.03	-1.41	0.02

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
ROCE (%)	--	6.38	6.09	6.28	9.87	9.46
ROE (%)	2.79	3.02	3.82	3.33	6.31	6.98
ROA (%)	1.42	1.36	1.58	1.41	2.74	3.05
EBIT Margin (%)	0.86	0.20	1.20	1.47	1.91	1.07
Net Margin (%)	0.99	0.83	1.16	0.89	1.32	1.83
Cash Profit Margin (%)	--	1.26	1.60	1.28	1.73	2.13

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Revenue Growth (%)	-7.69	19.19	-5.09	-14.98	41.43	16.10
EBIT Growth (%)	146.05	-80.08	-22.19	-34.65	152.20	59.53
Net Profit Growth (%)	0.51	-14.09	24.20	-42.47	0.62	12.44
EPS Growth (%)	0.51	-15.29	12.38	-42.47	-7.31	12.44
Book Value Growth (%)	--	4.34	13.22	3.39	15.31	7.24

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Price / Earnings	73.36	23.84	26.76	15.93	16.03	8.33
Price / Book Value	1.87	0.71	0.96	0.52	0.94	0.56
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	27.19	10.17	13.59	9.29	8.47	6.14
Close Price (₹)	90.16	33.51	43.65	24.00	41.45	23.20
High Price (₹)	100.00	75.75	68.00	51.25	64.40	42.00
Low Price (₹)	50.31	31.30	22.15	21.90	22.15	13.10
Market Cap (₹ Cr)	306.37	95.93	125.34	60.08	105.09	54.25

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debt to Equity	0.01	0.26	0.24	0.33	0.13	0.19
Short term debt to equity ratio	--	0.24	0.21	0.28	0.10	0.18
Current Ratio	1.81	1.78	1.70	1.61	1.73	1.67
Quick Ratio	1.53	1.48	1.49	1.44	1.62	1.53
Interest Coverage	1.75	2.31	2.22	3.10	5.93	4.40

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debtors to sales (%)	31.27	28.16	46.39	45.30	27.66	46.50
Asset Turnover	1.41	1.60	1.34	1.56	2.06	1.63
Receivable days	--	122.43	171.77	142.04	110.48	135.22
Inventory Days	--	30.87	29.14	18.51	11.91	18.57
Payable days	--	93.08	124.60	108.80	86.14	102.62
Cash Conversion Cycle	--	60.21	76.31	51.75	36.24	51.17

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)